As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to apply to a newly established review board for approval. Once its treatment is rubber-stamped, the…
In venture capital, the deck is theater. The real signal comes from the founder sitting across the table. Three traits can reveal more about a company’s future than any slide ever will.
AI adoption is rising in the U.S., but trust remains low, with most Americans concerned about transparency, regulation, and the technology’s broader societal impact, according to a new Quinnipiac poll.
Among the premium features on Instagram is the ability to view a Story without the poster seeing that you viewed it and the option to see how many people have rewatched your Story.